Yuhuan Wang1, Kai Su1, Nadezhda S Sabeva2, Ailing Ji3, Deneys R van der Westhuyzen4, Fabienne Foufelle5, Xia Gao6, Gregory A Graf7. 1. Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA. 2. Department of Neuroscience, Universidad Central del Caribe, Bayamón, PR, USA. 3. Department of Internal Medicine and Molecular, University of Kentucky, Lexington, KY, USA; Department of Cellular Biochemistry, University of Kentucky, Lexington, KY, USA. 4. Graduate Center for Nutritional Sciences, Saha Cardiovascular Research Center and Barnstable Brown Kentucky Diabetes and Obesity Center, Lexington, KY, USA; Department of Internal Medicine and Molecular, University of Kentucky, Lexington, KY, USA; Department of Cellular Biochemistry, University of Kentucky, Lexington, KY, USA. 5. INSERM, UMR-S 872, Centre de Recherches des Cordeliers, 15 rue de L'école de Médecine, Paris, France. 6. Department of Biochemistry, University of Alberta, Edmonton, AB, Canada. 7. Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA; Graduate Center for Nutritional Sciences, Saha Cardiovascular Research Center and Barnstable Brown Kentucky Diabetes and Obesity Center, Lexington, KY, USA. Electronic address: Gregory.Graf@uky.edu.
Abstract
OBJECTIVE: Mice lacking leptin (ob/ob) or its receptor (db/db) are obese, insulin resistant, and have reduced levels of biliary cholesterol due, in part, to reduced levels of hepatic G5G8. Chronic leptin replacement restores G5G8 abundance and increases biliary cholesterol concentrations, but the molecular mechanisms responsible for G5G8 regulation remain unclear. In the current study, we used a series of mouse models to address potential mechanisms for leptin-mediated regulation of G5G8. METHODS AND RESULTS: We acutely replaced leptin in ob/ob mice and deleted hepatic leptin receptors in lean mice. Neither manipulation altered G5G8 abundance or biliary cholesterol. Similarly, hepatic vagotomy had no effect on G5G8. Alternatively, G5G8 may be decreased in ob/ob and db/db mice due to ER dysfunction, the site of G5G8 complex assembly. Overexpression of the ER chaperone GRP78 using an adenoviral vector restores ER function and reduces steatosis in ob/ob mice. Therefore, we determined if AdGRP78 could rescue G5G8 in db/db mice. As in ob/ob mice, AdGRP78 reduced expression of lipogenic genes and plasma triglycerides in the db/db strain. Both G5 and G8 protein levels increased as did total biliary cholesterol, but in the absence of changes in G5 or G8 mRNAs. The increase in G5G8 was associated with increases in a number of proteins, including the ER lectin chaperone, calnexin, a key regulator of G5G8 complex assembly. CONCLUSIONS: Leptin signaling does not directly regulate G5G8 abundance. The loss of G5G8 in mice harboring defects in the leptin axis is likely associated with compromised ER function.
OBJECTIVE:Mice lacking leptin (ob/ob) or its receptor (db/db) are obese, insulin resistant, and have reduced levels of biliary cholesterol due, in part, to reduced levels of hepatic G5G8. Chronic leptin replacement restores G5G8 abundance and increases biliary cholesterol concentrations, but the molecular mechanisms responsible for G5G8 regulation remain unclear. In the current study, we used a series of mouse models to address potential mechanisms for leptin-mediated regulation of G5G8. METHODS AND RESULTS: We acutely replaced leptin in ob/ob mice and deleted hepatic leptin receptors in lean mice. Neither manipulation altered G5G8 abundance or biliary cholesterol. Similarly, hepatic vagotomy had no effect on G5G8. Alternatively, G5G8 may be decreased in ob/ob and db/db mice due to ER dysfunction, the site of G5G8 complex assembly. Overexpression of the ER chaperone GRP78 using an adenoviral vector restores ER function and reduces steatosis in ob/ob mice. Therefore, we determined if AdGRP78 could rescue G5G8 in db/db mice. As in ob/ob mice, AdGRP78 reduced expression of lipogenic genes and plasma triglycerides in the db/db strain. Both G5 and G8 protein levels increased as did total biliary cholesterol, but in the absence of changes in G5 or G8 mRNAs. The increase in G5G8 was associated with increases in a number of proteins, including the ER lectin chaperone, calnexin, a key regulator of G5G8 complex assembly. CONCLUSIONS:Leptin signaling does not directly regulate G5G8 abundance. The loss of G5G8 in mice harboring defects in the leptin axis is likely associated with compromised ER function.
Authors: Xia Gao; Jelske N van der Veen; Linfu Zhu; Todd Chaba; Marta Ordoñez; Susanne Lingrell; Debby P Y Koonen; Jason R B Dyck; Antonio Gomez-Muñoz; Dennis E Vance; René L Jacobs Journal: J Hepatol Date: 2014-11-27 Impact factor: 25.083
Authors: P Cohen; C Zhao; X Cai; J M Montez; S C Rohani; P Feinstein; P Mombaerts; J M Friedman Journal: J Clin Invest Date: 2001-10 Impact factor: 14.808
Authors: Karen Alejandra Méndez-Lara; Núria Farré; David Santos; Andrea Rivas-Urbina; Jari Metso; José Luis Sánchez-Quesada; Vicenta Llorente-Cortes; Teresa L Errico; Enrique Lerma; Matti Jauhiainen; Jesús M Martín-Campos; Núria Alonso; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Josep Julve Journal: Int J Mol Sci Date: 2019-02-02 Impact factor: 5.923